* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Factors Associated With the Mediastinal Spread of Cervical
Survey
Document related concepts
Transcript
Factors Associated With the Mediastinal Spread of Cervical Necrotizing Fasciitis Franck Petitpas, MD, Jean-Philippe Blancal, MD, Joaquim Mateo, MD, Iyed Farhat, MD, Walid Naija, MD, Raphael Porcher, PhD, Catherine Beigelman, MD, Mourad Boudiaf, MD, Didier Payen, PhD, MD, Philippe Herman, PhD, MD, and Alexandre Mebazaa, PhD, MD GENERAL THORACIC Departments of Anesthesiology and Critical Care, ENT, and Radiology, Lariboisière University Hospital, Paris; Department of Biostatistics and Clinical Epidemiology, Saint-Louis University Hospital, Paris; Department of Radiology, La Pitié Salpétrière University Hospital, Paris; University Paris 7, Pres Sorbonne Paris Cité, Paris; and INSERM U942, Paris, France Background. We conducted a study to determine factors associated with the occurrence of mediastinitis in patients hospitalized for cervical necrotizing fasciitis (CNF). Methods. We reviewed the medical records of 130 consecutive patients in an intensive care unit (ICU) who were hospitalized with a diagnosis of CNF. Two radiologists reviewed cervical and thoracic computed tomography (CT) scans to determine the source and extension of the infection in each patient. Results. Among the cohort of 130 patients with CNF, 37 (28%) had mediastinitis at the time of their admission (which in 13 cases was superior, or above the aortic arch, and in 24 cases inferior). Cervical necrotizing fasciitis complicated by mediastinitis resulted in a longer stay in the ICU than did CNF without mediastinitis, of a mean of 29 days (range, 18 to 39 days) versus 14 days (range, 9 to 19) days, respectively (p < 0.0001). Multivariate analysis revealed that the presence of mediastinitis was associated with oral intake of glucocorticoids before admission (odds ratio [OR], 2.17; range, 0.99 to 4.76), a pharyngeal focus of CNF (OR, 2.17; range, 1.04 to 4.53), or gas seen on an initial CT scan (OR, 4.49; range, 2.15 to 9.38). Both a pharyngeal focus of fasciitis and the presence of gas were strong independent predictors of inferior mediastinitis (OR, 15.1; range, 4.9 to 46.4; p < 0.0001). Conclusions. The present study is the first to describe three independent factors associated with extension of cervical fasciitis to the thoracic cavity, including glucocorticoid intake before admission, and confirms previous reports of a high incidence of mediastinitis in patients with CNF. (Ann Thorac Surg 2012;93:234 –9) © 2012 by The Society of Thoracic Surgeons N Material and Methods ecrotizing fasciitis is an acute soft-tissue infection that usually involves the extremities and perianal areas, and more rarely the head and neck, including the periorbital region [1]. Typically, necrotizing fasciitis is the result of a local infection spreading throughout the skin and resulting in dermal, subcutaneous, and deep fascial acute pyogenic infection. Necrotizing fasciitis can also rapidly expand into adjacent tissues and organs in a fulminant course of infection. Factors causing the distant spread of necrotizing fasciitis are unknown. Cervical necrotizing fasciitis (CNF) is a life-threatening infection originating chiefly from dental or oropharyngeal infection. It may spread to the chest, leading to a “descending” mediastinitis, which is the most virulent complication of CNF. We conducted a study to assess factors that facilitate the spread of CNF into the mediastinum, for which we retrospectively analyzed data for 130 consecutive patients with CNF. Accepted for publication Sept 2, 2011. Address correspondence to Dr Mebazaa, Department of Anesthesiology and Critical Care, Lariboisière Hospital, University Paris 7, UMR 942 INSERM, 2 rue Ambroise Paré, 75010 Paris, France; e-mail: alexandre. [email protected]. © 2012 by The Society of Thoracic Surgeons Published by Elsevier Inc Lariboisière Hospital is the reference center for medical and surgical management of CNF in Paris and the surrounding region. The 130 patients whose data we reviewed were patients admitted to the Hospital for CNF between 1999 and 2006. Approval for the retrospective collection of data and the data analysis for the study was given by the Institutional Review Board of Paris North Hospitals. The diagnosis of CNF was confirmed with contrastenhanced computed tomography (CT) of the cervical neck and chest upon the admission of each patient to the hospital. After confirmation of the diagnosis, antibiotic therapy was administered in the following regimen before surgery was done: ceftriaxone (4 g/d loading dose for 2 days, followed by maintenance doses of 2 g/d) plus ornidazole (3 g/d loading dose for 2 days, followed by maintenance doses of 1.5 g/d), with both drugs continued for 14 days. In patients with CNF-related mediastinitis, the antibiotic regimen was extended for up to another 7 days. A bilateral cervicotomy was then done for the collection of samples for microbiologic examination, together with the early debridement of all necrotic tissue and drainage of all fascial planes. Debridement of the 0003-4975/$36.00 doi:10.1016/j.athoracsur.2011.09.012 cervical region was then repeated, chiefly in the ICU, at least twice daily until healthy fascia was encountered. Surgical management was guided by the findings on chest CT scanning. If the extension of CNF was limited to the area above the aortic arch, in which case it was designated as “superior” mediastinitis, or type I mediastinitis as defined by by Endo and colleagues [2], drainage of mediastinal infection was performed through the cervicotomy described above. When signs of infection were found below the aortic arch, in what was termed “inferior” mediastinitis, or type II mediastinitis as defined by Endo and colleagues, immediate sternotomy was done (including the removal of a necrotic thymus in the case of anteroinferior mediastinal extension) or thoracotomy was done (in the case of posteroinferior mediastinal extension), typically at the time of cervicotomy or, in a very few cases, within 12 hours of cervicotomy. Because the mediastinum is in contact with the “open” cervical area, no vacuum-assisted losure (VAC) system can be used in the latter procedure. However, drains were put in place in the retrosternal or the posterior region of the mediastinum or both, to allow continuous irrigation. Data Collection To assess the factors that lead to distal expansion of CNF in the chest, the study patients’ data were reviewed. Severity of illness was assessed with the Simplified Acute Physiology Score II (SAPS II) and the Sequential Organ Failure Assessment (SOFA) score [3, 4]. To determine the source of CNF and the level of mediastinal involvement, the initial CT scan was retrospectively reviewed by two radiologists blinded to the surgical findings and the outcome of the patient. Although no recording was made of the interval between the suspicion of infection and the beginning of antibiotic treatment given by the physician treating the patient before the patient’s admission, the interval between antibiotic treatment and admission to the hospital was available. A diagnosis of CNF was based on the finding of diffuse thickening of subcutaneous fat, cervical fascia, and cervical muscles. The presence of fluid or gas collections or both was recorded. The results of this were compared with the findings at surgery. Statistical Analysis Results are expressed as mean ⫾ standard deviation (SD), median and first and third quartiles (Q1 to Q3), or counts and percentages, as appropriate. Study outcomes were mediastinitis and inferior mediastinitis, the data for each of which were analyzed separately. Marginal association between single variables and each outcome was assessed with Wilcoxon’s rank-sum test for quantitative variables and with the 2 or Fisher’s exact test when appropriate for qualitative variables. Multiple logistic regression analysis was used to identify a set of variables independently associated with each outcome. Variables associated with the occurrence of mediastinitis at a level of p ⬍ 0.15 were considered in the multiple models. A backward stepwise procedure was used for the selection of variables, with a cut-off value of PETITPAS ET AL FACTORS ASSOCIATED WITH MEDIASTINITIS IN CNF 235 p ⫽ 0.05. First-order interactions between selected variables were then tested. For inferior mediastinitis, Because of the moderate number of instances of inferior mediastinitis, data reduction through heuristic shrinkage was done before the use of multivariate analysis, without considering the association of variables with the outcome [5]. The first-order interaction between variables marginally associated with the outcome was then tested before the backward stepwise procedure. The Cessie and van Houwelingen goodness-of-fit test [6] was used to verify the validity of the logistic regression model. Internal validation of the models was performed by bootstrapping [7]. The procedure was based on a random generation of 200 samples from the original data, which were drawn with replacement. The whole-variableselection procedure was applied to these samples, and the performance measures of the derived model were calculated. The discriminative ability of the models was evaluated with the c index (which is identical to the area under the receiver operating characteristics [ROC] curve) [8] and through calibration with the calibration slope [9]. The performances of the models estimated on the basis of each bootstrap sample were then evaluated in the original sample. The differences between the performance of the selected model in the bootstrap sample and the original sample were taken as a measure of the overoptimism of the model. The performance of the final model was then corrected by this over-optimism (ie, the area under the ROC curve was reduced accordingly), and estimated regression coefficients were multiplied by the calibration slope. All tests were two-sided. Analyses were done with R statistical software (R Foundation for Statistical Computing, Vienna, Austria). Results During the 8-year period in which the study data were collected, our hospital admitted 130 patients for CNF. Most were referred from emergency rooms, general practitioners, or ear, nose, and throat practices in Paris and its suburbs. The patients had been given oral antibiotics (64%), nonsteroidal anti-inflammatory drugs (NSAIDs) (40%), or glucocorticoids (26%) for an average of 4 days before their admission to the hospital (Table 1). Most of the patients were self-ventilating and were not taking catecholamines at the time of their admission. Mediastinitis was always discovered by CT scanning rather than being suspected on the basis of clinical or biologic signs. Patients with high illness severity scores (SAPS II score of 35 ⫾ 13 and median SOFA of 3 [1–5]) were transferred postoperatively to the intensive care unit (ICU). Imaging with CT showed signs of CNF in all of the patients studied, and allowed the assessment of pharyngeal and dental infections as the two most frequent causes of CNF (42% and 37%, respectively). Notably, gas was present in the CT scans of 31% of the patients. Signs found in CT scanning were confirmed by surgical findings. GENERAL THORACIC Ann Thorac Surg 2012;93:234 –9 236 PETITPAS ET AL FACTORS ASSOCIATED WITH MEDIASTINITIS IN CNF Ann Thorac Surg 2012;93:234 –9 Table 1. Patient History, Sociodemographic, and Clinical Data at Admission CNF With Mediastinitis Patient Data GENERAL THORACIC Number of patients Epidemiologic findings Age (years) Male Smoking Alcoholism Diabetes Medications before admission Antibiotics Glucocorticoids NSAIDs Severity score at admission SAPS II SOFA [median (Q1–Q3)] CNF source Pharyngeal Dental Other Presence of gas Bacteria, n (%) Number of bacteria isolated/patient Streptococcus milleri Anaerobic bacilli Coagulase-negative Staphylococcus Streptococcus pyogenes Streptococcus oralis Enterobacter Staphylococcus aureus Fungi Others Outcome [median (Q1–Q3)] Duration of mechanical ventilation (d) Length of stay in ICU (d) Mortality at 28 d [n (%)] CNF With Superior Mediastinitis CNF With Inferior Mediastinitis Presence (n ⫽ 37) vs Absence of Mediastinitis (n ⫽ 93) Inferior (n ⫽ 24) vs Absence of Mediastinitis/ Superior Mediastinitis (n ⫽ 106) Total CNF Without Mediastinitis 130 93 (72%) 13 (10%) 24 (18%) 48 ⫾ 18 75 (58%) 58 (45%) 25 (19%) 8 (6%) 47 ⫾ 17 56 (60%) 45 (48%) 21 (23%) 6 (6%) 45 ⫾ 15 6 (46%) 4 (31%) 0 (0%) 1 (8%) 58 ⫾ 19 13 (54%) 9 (38%) 4 (17%) 1 (4%) 0.065 0.43 0.0086 0.82 83 (65%) 35 (27%) 52 (40%) 59 (64%) 19 (20%) 37 (40%) 7 (58%) 5 (38%) 6 (46%) 17 (71%) 11 (46%) 9 (38%) 0.84 0.015 0.84 0.64 0.039 0.82 35 ⫾ 13 3 (1–6) 34 ⫾ 14 2 (1–5) 31 ⫾ 10 4 (2–7) 40 ⫾ 11 4 (2–7) 0.49 0.046 0.0047 0.07 55 (42%) 48 (37%) 27 (21%) 39 (31%) 33 (35%) 40 (43%) 20 (21%) 18 (20%) 5 (38%) 2 (15%) 6 (46%) 7 (54%) 17 (71%) 6 (25%) 1 (4%) 14 (58%) 0.018 0.027 0.0026 0.24 ⬍0.0001 0.0025 2.7 ⫾ 1.5 2.6 ⫾ 1.6 2.2 ⫾ 1.5 3.3 ⫾ 1.8 0.3 0.043 70 (54%) 80 (62%) 16 (12%) 49 (53%) 56 (60%) 12 (13%) 6 (46%) 6 (46%) 2 (15%) 15 (62%) 18 (75%) 2 (8%) 0.85 0.69 1.0 0.5 0.17 0.73 12 (9%) 4 (3%) 6 (5%) 4 (3%) 7 (5%) 25 (19%) 9 (10%) 3 (3%) 4 (4%) 3 (3%) 5 (5%) 16 (17%) 3 (23%) 0 (0%) 1 (8%) 0 (0%) 1 (8%) 3 (23%) 0 (0%) 1 (4%) 1 (4%) 1 (4%) 1 (4%) 6 (25%) 1.0 1.0 1.0 1.0 1.0 0.46 0.12 0.57 1.0 0.57 1.0 0.57 12 (8–18) 10 (7–16) 16 (10–24) 20 (14–27) ⬍0.0001 ⬍0.0001 16 (10–25) 11 (8 %) 14 (9–19) 5 (5 %) 21 (12–33) 2 (15 %) 30 (22–46) 4 (17 %) ⬍0.0001 0.075 ⬍0.0001 0.12 CNF ⫽ cervical necrotizing fascitis; ICU ⫽ intensive care unit; NSAIDs ⫽ nonsteroidal antiinflammatory medications; Q1 ⫽ first quartile; Q3 ⫽ third quartile; SAPS II ⫽ Simplified Acute Physiology Score II; SOFA ⫽ Sequential Organ Failure Assessment Score. As previously described, the most frequent bacteria found in necrotic tissues were Streptococcus milleri and anaerobic bacilli (in 54% and 62% of samples, respectively) [10]. Expansion of CNF toward the mediastinum was present in 37 patients (28%). All cases of mediastinitis were detected on a first contrast-enhanced CT scan, done at the time of admission to our center, and later confirmed by surgery. These 37 patients had a higher incidence of oral glucocorticoid ingestion before admission than did patients without mediastinitis (43% versus 20%, respectively; p ⫽ 0.015) (Table 1). The source of CNF associated with mediastinitis was predominantly pharyngeal (59%), and included gas-producing bacteria in more than 50% of the cases of such disease. On admission, 13 of the 37 cases of CNF-related mediastinitiswere superior and 24 were inferior (above and below the aortic arch, respectively) according to the definitions of Endo and colleagues [2]. No patient had newly discovered mediastinitis in the 90 days after admission for CNF, if the mediastinitis was present at admission. Furthermore, no “superior” mediastinitis extended to inferior mediastinum during ICU stay. PETITPAS ET AL FACTORS ASSOCIATED WITH MEDIASTINITIS IN CNF Patients with mediastinitis had a longer duration of mechanical ventilation and ICU stay than those without it (both, p ⬍ 0.0001) (Table 1). Any mediastinal involvement also resulted in a higher, albeit not statistically significant, mortality (16% vs 5%, respectively, p ⫽ 0.075). Patients with inferior mediastinitis were sicker on admission (SAPS II, 40 ⫾ 11) and required a longer ICU stay (mean, 30 days; range, 22 to 46 days) than did those with superior mediastinitis (Table 1). Multivariate analysis (Table 2) showed that extension of CNF to the chest was independently associated with oral glucocorticoid use before admission (OR, 2.17; range, 0.99 to 4.76), a pharyngeal source of CNF (OR, 2.17; range, 1.04 to 4.53), or the presence of gas in both the source of infection and its extension on the initial CT scan (OR, 4.49; range, 2.15 to 9.38). The combination of a pharyngeal source of CNF and the presence of gas (test for interaction: p ⫽ 0.023) was a strong predictor of the extension of CNF to below the aortic arch, also called inferior mediastinitis (OR, 15.1; range, 4.9 to 46.4; p ⬍ 0.0001) (Table 2). Comment Our study showed that the production of gas was associated with a greater incidence of expansion of CNF into the chest. Indeed, the combination of a pharyngeal infection with the production of gas increased the risk of extension into the inferior mediastinum by 15-fold. This study involved the largest population of patients with CNF who were treated with surgery and had follow-up in the ICU. Expansion of CNF toward the mediastinum was found in 28% of the patients. This was in accordance with prior reports in the literature, which had had several limitations in terms of etiology and disease course. Cervical necrotizing fasciitis results from the extension of infection from a pharyngeal or odontogenic source. The infection spreads along the fascia, often in an ipsilateral fashion, but not hematogenously. The infection Table 2. Factors Associated With Mediastinitis in Patients Admitted for Cervical Nectrotizing Fasciitis Multivariate Analysis Patient Data OR All Mediastinitis Variables Production of gas by infecting organism Pharyngeal origin Oral glucocorticoid intake Inferior Mediastinitis Parameters Pharyngeal source and gas production SAPS II CI ⫽ confidence interval; Acute Physiology Score II. 95% CI p Value 4.49 2.15–9.4 ⬍0.0001 2.17 2.17 1.04–4.58 0.99–4.76 0.039 0.054 4.9–46.4 ⬍0.0001 15.1 1.5 OR ⫽ odds ratio; 1.1– 2.2 0.016 SAPS II ⫽ Simplified 237 may further expand toward the mediastinum into pretracheal, perivascular, and prevertebral spaces, bound anteriorly by the alar fascia and posteriorly by the prevertebral fascia, and known collectively as the “danger space” because of its patency from the base of the skull to the diaphragm [11]. Both dental and pharyngeal infections can extend into the mediastinum[12, 13]. In our study, pharyngeal infections were more liable to cause mediastinitis, a finding not demonstrated in previous studies based on smaller case series[14 –17]. Reynolds and associates emphasized that pharyngeal infections can spread through retropharyngeal and prevertebral spaces from the base of the skull to the diaphragm [11], as noted above. This lack of inherent protection brings about the rapid onset of a life-threatening mediastinitis. The mechanisms by which CNF expands into the mediastinum remain unclear. The expansion may be due to mechanical or chemical properties or both of the gas produced by the bacteria causing the fasciitis, or may directly indicate virulence of the causative bacteria. If it is produced in large quantities, such gas may dissect the tissues, especially along the fascial planes. The anaerobic bacteria found in our patients, such as Prevotella spp., Peptostreptococcus spp., also produce non-olatile fatty acids (including succinic and phenylacetic acids) that may decrease extracellular pH in the surrounding tissues leading to cellular alterations that include leukocyte inactivation [18]. The present study shows that oral glucocorticoid intake, but not NSAIDs, put patients at an increased risk of expansion of CNF into the mediastinum (p ⫽ 0.015). The mechanism responsible for such expansion of CNF in patients taking glucocorticoids is unknown. Glucocorticoid use may have diminished initial clinical signs of this expansion and delayed the surgical debridement of affected tissues, or may have favored the spread of infection to the mediastinum, at least partly via these drugs’ immunosuppressive properties. Hence, until new data appear, and for the sake of safety, the use of glucocorticoids should not be advocated for the early resolution of pain in acute pharyngitis, despite the lack of any previour report of a complication such as the mediastinal spread of CNF. The present study has important clinical implications in the management of CNF. It revealed gas on CT imaging in 31% of our CNF patients, and the absence of gas in the remaining 69% confirming that the absence of gas does not rule out CNF, in contrast with the findings in another recent study [19]. We also confirm that there is a continuum between CNF and descending mediastinitis: cervical infection may spread first to the superior and eventually to the lower mediastinum. We strongly recommend CT scanning at the time of admission of patients with CNF to assess the source of infection, production of gas, and any expansion of infection [20]. Early and aggressive treatment based on the findings made with CT may stop further downward expansion of the infection [21]. This strategy, along with experience (more than 16 cases of CNF per year seen in our center versus fewer GENERAL THORACIC Ann Thorac Surg 2012;93:234 –9 238 PETITPAS ET AL FACTORS ASSOCIATED WITH MEDIASTINITIS IN CNF GENERAL THORACIC than 5 cases per year in other studies [22]), may reduce the mortality rate and length of stay in the ICU for patients with CNF below those in prior studies [22–24]. Despite monocentricity, our findings lead us to conclude that: (1) mediastinitis was always present in patients admitted to our hospital for CNF, (2) no further expansion of CNF was observed when patients received appropriate and aggressive treatment beginning at the time of admission, and (3) two subgroups of mediastinitis can be defined, consisting of superior and inferior mediastinitis. Superior mediastinitis was limited to the area above the aortic arch and was treated through cervicotomy[25]. Inferior mediastinitis, below the aortic arch, required a combined cervical and thoracic surgical approach [24] with a much longer ICU stay. Three factors independently predicted extension of CNF to the mediastinum: (1) a pharyngeal origin of CNF, (2) the presence of gas in the source site of infection, and (3) oral glucocorticoid intake before admission to the hospital. In summary, our study confirms a high incidence of mediastinitis in a considerable number of patients with CNF. As noted above, three independent factors appeared to indicate the expansion of cervical infection toward the mediastinum: (1) a pharyngeal source of infection, (2) the presence of gas in the source site of infection, and (3) oral intake of glucocorticoids before hospital admission. Our study thus challenges the use of glucocorticoids in local infections such as dental or pharyngeal infections, and emphasizes the need for additional studies of mediastinitis in CNF. Should our results be confirmed by other studies, the use of glucocorticoids in acute pharyngitis or dental infection should be re-examined. The authors thank Professor Luc Dubreuil (Lille) for his advice, and Professors Bernard Regnier (Université Paris 7) and Mervyn Singer (London) for editing this paper. The authors also wish to thank the assistants in the Ear, Nose, and Throat Department of the Lariboisiere University Hospital who contributed to the surgical management of these patients, as well as all health providers in the Ear, Nose, and Throat Department, Intensive Care Unit, and Recovery Unit of the Lariboisière Hospital for their hard work in treating the critically ill patients in this study. The authors also thank their colleagues for their dedication, which made this work possible: Elisabeth Sauvaget, Franck Schaulievge, Alain Bel, Anne-Claire Lukascewicz, Sophie Dagois, Corinne Dematons, Peter Karpati, and Romain Kania. In memoriam of Christine Berton. This study was partly supported by grant EA 322, DP from the Ministère de l’Enseignement et de la Recherche of France. References 1. Swartz MN. Clinical practice. Cellulitis. N Engl J Med 2004;350:904 –12. 2. Endo S, Murayama F, Hasegawa T, et al. Guideline of surgical management based on diffusion of descending necrotizing mediastinitis. Jpn J Thorac Cardiovasc Surg 1999;47:14 –9. 3. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957– 63. Ann Thorac Surg 2012;93:234 –9 4. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsisrelated Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intens Care Med 1996;22:707–10. 5. Harrell FE, Jr., Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361– 87. 6. Le Cessie S, van Houwelingen JC. A goodness of fit test for binary regression models, based on smoothing methods. Biometrics 1991;47:1267– 82. 7. Steyerberg EW, Eijkemans MJ, Harrell FE, Jr., Habbema JD. Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets. Med Decis Making 2001;21:45–56. 8. Harrell FE, Jr., Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA 1982;247:2543– 6. 9. Miller ME, Hui SL, Tierney WM. Validation techniques for logistic regression models. Stat Med 1991;10:1213–26. 10. Fihman V, Raskine L, Petitpas F, et al. Cervical necrotizing fasciitis: 8-years’ experience of microbiology. Eur J Clin Microbiol Infect Dis 2008;27:691–5. 11. Reynolds SC, Chow AW. Life-threatening infections of the peripharyngeal and deep fascial spaces of the head and neck. Infect Dis Clin North Am 2007;21:557–76, viii. 12. Righini CA, Motto E, Ferretti G, Boubagra K, Soriano E, Reyt E. [Diffuse cervical cellulites and descending necrotizing mediastinitis]. Ann Otolaryngol Chir Cervicofac 2007;124: 292–300. 13. Thomas SJ, Atkinson C, Hughes C, Revington P, Ness AR. Is there an epidemic of admissions for surgical treatment of dental abscesses in the UK? BMJ 2008;336:1219 –20. 14. Freeman RK, Vallieres E, Verrier ED, Karmy-Jones R, Wood DE. Descending necrotizing mediastinitis: an analysis of the effects of serial surgical debridement on patient mortality. J Thorac Cardiovasc Surg 2000;119:260 –7. 15. Levine TM, Wurster CF, Krespi YP. Mediastinitis occurring as a complication of odontogenic infections. Laryngoscope 1986;96:747–50. 16. Panda NK, Simhadri S, Sridhara SR. Cervicofacial necrotizing fasciitis: can we expect a favourable outcome? J Laryngol Otol 2004;118:771–7. 17. Sancho LM, Minamoto H, Fernandez A, Sennes LU, Jatene FB. Descending necrotizing mediastinitis: a retrospective surgical experience. Eur J Cardiothorac Surg 1999;16:200 –5. 18. Hanly EJ, Aurora AA, Shih SP, et al. Peritoneal acidosis mediates immunoprotection in laparoscopic surgery. Surgery 2007;142:357– 64. 19. Lee JW, Immerman SB, Morris LG. Techniques for early diagnosis and management of cervicofacial necrotising fasciitis. J Laryngol Otol;124:759 – 64. 20. Pinto A, Scaglione M, Scuderi MG, Tortora G, Daniele S, Romano L. Infections of the neck leading to descending necrotizing mediastinitis: role of multi-detector row computed tomography. Eur J Radiol 2008;65:389 –94. 21. Boyer A, Vargas F, Coste F, et al. Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management. Intens Care Med 2009;35:847–53. 22. Mathieu D, Neviere R, Teillon C, Chagnon JL, Lebleu N, Wattel F. Cervical necrotizing fasciitis: clinical manifestations and management. Clin Infect Dis 1995;21:51– 6. 23. Mohammedi I, Ceruse P, Duperret S, Vedrinne J, Bouletreau P. Cervical necrotizing fasciitis: 10 years’ experience at a single institution. Intensive Care Med 1999;25:829 –34. 24. Roccia F, Pecorari GC, Oliaro A, et al. Ten years of descending necrotizing mediastinitis: management of 23 cases. J Oral Maxillofac Surg 2007;65:1716 –24. 25. Chen KC, Chen JS, Kuo SW, et al. Descending necrotizing mediastinitis: a 10-year surgical experience in a single institution. J Thorac Cardiovasc Surg 2008;136:191– 8.